Human immunodeficiency virus type 1 entry into murine cell lines and lymphocytes from transgenic mice expressing a glycoprotein 120-binding mutant mouse CD4

AIDS Research and Human Retroviruses

Volumn 12, Issue 10, 1996, Pages 867-876

  Wieder, Kenneth J ^a   Chatis, Pamela ^a   Boltax, Jay ^a   Wieder, Irene ^a   Nuovo, Gerard ^b   Strom, Terry B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAG PROTEIN; GLYCOPROTEIN GP 120; MUTANT PROTEIN; RNA DIRECTED DNA POLYMERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS REPLICATION;

EID: 0029957131     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.867     Document Type: Article

References (44)

1. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, and Weiss RA: The CD4 (T4) T antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London) 1984;312:763-766.
2. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, and Montagnier L: T-lymphocyte T4 molecule behaves as the receptor for the human retrovirus LAV. Nature (London) 1984;312:767-768.
3. Stein BS, Gowda SD, Lifson JD, Penhallow RC, Bensch KG, and Engleman EG: pH-independent HIV entry into CD4 positive T cells via virus envelope fusion to the plasma membrane. Cell 1987;49:659-668.
4. Pauza CD and Price TM: Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J Cell Biol 1988;107:959.
5. Landau NR, Warton M, and Littman DR: The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature (London) 1988; 334:159-162.
6. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, and Axel R: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986; 47:333-348.
7. Clapham PR, Blanc D, and Weiss RA: Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 1991;181:703-715.
8. Jasin M, Page KA, and Littman DR: Glycosylphosphatidylinositol-anchored/CD4 thy-1 chimeric molecules serve as human immunodeficiency virus receptors in human, but not mouse, cells and are modulated by gangliosides. J Virol 1991;65:440-444.
9. Page KA, Landau NR, and Littman DR: Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J Virol 1990;65:5270-5276.
10. Simon JHM, Schockmel GA, Illei P, and James W: A rodent cell line permissive for entry and reverse transcription of human immunodeficiency virus type 1 has a pre-integration block to productive infection. J Gen Virol 1994;75:2615-2623.
11. Lores P, Boucher V, Mackay C, Pla M, Boehmer HV, Jami J, Barre-Sinoussi F, and Weill JC: Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection. AIDS Res Hum Retroviruses 1992;8:2063-2071.
12. Barre-Sinoussi F, Lores P, Mackay C, Boucher V, Nguyen VC, Pla M, Weill JC, and Jami J: HFV infection studies in human CD4 transgenic mice. Int. Conf. AIDS 1990;6:351. [Abstract 1150]
13. Ashorn PA, Berger EA, and Moss B: Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J Virol 1990;64:2149-2156.
14. Dragic T, Chameau P, Clavel F, and Alizon M: Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol 1992;66:4794-4802.
15. Levy JA, Cheng-Mayer C, Dina D, and Luciw PA: AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. Science 1986;232:998.
16. Mizrachi Y, Sternas L, and Volsky DJ: The establishment of rodent cell lines persistently producing HIV-1. Virology 1992; 186:167-174.
17. Spector DH, Wade E, Wright DA, Koval V, Clark C, Jaquish D, and Spector SA: Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J Virol 1990;64:2298-2308.
18. Chesebro B, Wehrly K, and Maury W: Differential expression in human and mouse cells of human immunodeficiency virus pseudotyped by murine retroviruses. J Virol 1990;64:4553-4557.
19. Arthos J, Deen KC, Chaikin MA, Fornwald JA, Sathe G, Sattenau QJ, Clapham PR, Weiss RA, McDougal JS, Pietropaolo C, Axel R, Truneh A, Maddon PJ, and Sweet RW: Identification of the residents in human CD4 critical for the binding of HIV. Cell 1989;57:469-181.
20. Brodsky MH, Warton M, Myers RM, and Littman DR: Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J Immunol 1990;144:3078-3086.
21. Clayton LK, Hussey RE, Steinbrich R, Ramachandran H, Husain Y, and Reinherz EL: Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding. Nature (London) 1988;335:363-366.
22. Mizukami T, Fuerst TR, Berger EA, and Moss B: Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis. Proc Natl Acad Sci USA 1988; 85:9273-9277.
23. Peterson A, and Seed B: Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 1988;54:65-72.
24. Sattenau QJ, Arthos J, Deen K, Hanna N, Healey D, Beverley PC, Sweet R, and Truneh A: Structural analysis of the human immunodeficiency virus-binding domain of CD4. J Exp Med 1989; 170:1319-1334.
25. Sanger F, Nicklen S, and Coulson A: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74:5463-5467.
26. Littman DR and Gettner SN: Unusual intron in the immunoglobulin domain of the newly isolated CD4 (L3T4) gene. Nature (London) 1987;325:453-455.
27. Velu TJ, Beguinot L, Vass WC, Zhang K, Pastan I, and Lowy DR: Retroviruses expressing different levels of the normal epidermal growth factor receptor: Biological properties and new bioassay. J Cell Biochem 1989;39:153-166.
28. Greaves DR, Wilson FD, Lang G, and Kioussis D: Human CD2 3′-flanking sequences confer high-level T-cell, position-independent gene expression in transgenic mice. Cell 1989;56:979-986.
29. Lang G, Wotton D, Owen MJ, Sewell WA, Brown MH, Mason DY, Crumpton MJ, and Kioussis D: The structure of the human CD2 gene and its expression in transgenic mice. EMBO J 1988;7:1675-1688.
30. Law YM, Yeung RSM, Mamalaki C, Kioussis D, Mak TW, and Flavell RA: Human CD4 restores normal T cell development and function in mice deficient in murine CD4. J Exp Med 1994;179:1233-1242.
31. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1982.
32. Schnittman SM, Psallidopoulos MC, Lane HC, Thompson L, Baseler M, Massari F, Fox CH, Salzman NP, and Fauci AS: The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 1989;245:868-871.
33. Nuovo GJ, Forde A, MacConnell P, and Fahrenwald R: In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. Am J Pathol 1993;143:40-48.
34. Nuovo GJ, Becker J, Burk MW, Margiotta M, Fuhrer J, and Steigbigel RT: In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS. J Acquir Immune Defic Syndr 1994;7:916-923.
35. Schockmel GA, Somoza C, Davis SJ, Williams AF, and Healey D: Construction of a binding site for human immunodeficiency virus type 1 gp120 in rat CD4. J Exp Med 1992;175:301-304.
36. Ryu SE, Kwong PD, Truneh A, Porter TG, Arthos J, Rosenberg M, Dai X, Xuong N, Axel R, Sweet RW, and Hendrickson WA: Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature (London) 1990;348:419-425.
37. Wang J, Tan Y, Garrett TPJ, Liu J, Rodgers DW, Garlick RL, Tarr GE, Husain Y, Reinherz EL, and Harrison SC: Atomic structure of a fragment of CD4 containing two immunoglobulin-like domains. Nature (London) 1990;348:411-418.
38. Trono D: Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J Virol 1992; 66:4893-4900.
39. Lori F, Veronese FDM, de Vico AL, Reitz Jr MS, and Gallo RC: Viral DNA carried by human immunodeficiency virus type 1 virions. J Virol 1992;66:5067-5074.
40. Locardi C, Puddu P, Ferrantini M, Parlanti E, Sestili P, Varano F, and Belardelli F: Persistent infection of normal mice with human immunodeficiency virus. J Virol 1992;66:1649-1654.
41. Trono D and Baltimore D: A human cell factor is essential for HIV-1 REV action. EMBO J 1990;9:4155-4160.
42. Alonso A, Derse D, and Peterlin BM: Human chromosome 12 is required for optimal interactions between tat of human immunodeficiency virus type 1 in rodent cells. J Virol 1992;66:4617-4621.
43. Hart CE, Ou C-Y, Galphin JC, Moore J, Bacheler LT, Wasmuth JJ, Petteway SR, and Schochetman G: Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science 1989;246:488-491.
44. Newstein M, Stanbridge EJ, Casey G, and Shank PR: Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells. J Virol 1990;64:4565-4567.